BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12421978)

  • 21. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes.
    Aittomäki S; Pesu M; Groner B; Jänne OA; Palvimo JJ; Silvennoinen O
    J Immunol; 2000 Jun; 164(11):5689-97. PubMed ID: 10820245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
    Guh JY; Huang JS; Chen HC; Hung WC; Lai YH; Chuang LY
    Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
    Miyatake S; Sakuma M; Saito T
    Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway.
    Yokoyama N; Reich NC; Miller WT
    J Interferon Cytokine Res; 2001 Jun; 21(6):369-78. PubMed ID: 11440634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
    Natarajan C; Sriram S; Muthian G; Bright JJ
    Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadd45gamma is dispensable for normal mouse development and T-cell proliferation.
    Hoffmeyer A; Piekorz R; Moriggl R; Ihle JN
    Mol Cell Biol; 2001 May; 21(9):3137-43. PubMed ID: 11287618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes.
    Biola A; Andréau K; David M; Sturm M; Haake M; Bertoglio J; Pallardy M
    FEBS Lett; 2000 Dec; 487(2):229-33. PubMed ID: 11150515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C; Ng J; Babbage JW; Cantrell DA
    EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
    Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
    Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4.
    Schindler H; Lutz MB; Röllinghoff M; Bogdan C
    J Immunol; 2001 Mar; 166(5):3075-82. PubMed ID: 11207258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.
    Kryworuchko M; Pasquier V; Keller H; David D; Goujard C; Gilquin J; Viard JP; Joussemet M; Delfraissy JF; Thèze J
    AIDS; 2004 Feb; 18(3):421-6. PubMed ID: 15090793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
    Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
    Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.
    Galigniana MD; Scruggs JL; Herrington J; Welsh MJ; Carter-Su C; Housley PR; Pratt WB
    Mol Endocrinol; 1998 Dec; 12(12):1903-13. PubMed ID: 9849964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
    Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
    J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling.
    Nelson BH; Martyak TP; Thompson LJ; Moon JJ; Wang T
    J Immunol; 2003 Jun; 170(11):5563-70. PubMed ID: 12759434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.